{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:20:49Z","timestamp":1787750449754,"version":"build-2784847793"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Fibrofolliculomas, benign adnexal tumors often associated with Birt\u2013Hogg\u2013Dub\u00e9 syndrome, exhibit characteristic perifollicular epithelial and stromal proliferation. Although their clinicopathologic features are well established, the molecular and metabolic drivers of stromal remodeling remain poorly understood, particularly in sporadic cases. We investigate the presence of dermal interstitial glycogenosis (DIG) and stromal senescence in fibrofolliculomas, exploring potential mechanistic parallels with pulmonary interstitial glycogenosis and mammalian target of rapamycin (mTOR)-driven cutaneous lesions. Archival skin biopsy specimens diagnosed as fibrofolliculoma between 2015 and 2025 (n = 13) were analyzed using Periodic acid\u2013Schiff \u00b1 diastase staining and immunohistochemistry for p53, GLB1 (\u03b2-galactosidase), CD68, and phospho-S6 and compared with age-matched, sex-matched, and site-matched controls (n = 3). Clinical data, including imaging and genetic testing, were reviewed in cases of fibrofolliculoma. All fibrofolliculomas exhibited diastase-sensitive Periodic acid\u2013Schiff-positive stromal granules consistent with glycogen accumulation. Stromal cells demonstrated immunoreactivity for GLB1, p53, and phospho-S6 in the absence of CD68 expression, indicating nonhistiocytic stromal senescence and mTOR activation. Birt\u2013Hogg\u2013Dub\u00e9 syndrome was suspected in 4 of 10 patients but unconfirmed; DIG and senescence markers were present regardless of clinical context. Glycogenosis and cellular senescence markers were absent in controls. These findings identify DIG and stromal senescence as conserved features of fibrofolliculomas, suggesting a metabolic\u2013senescence axis driven by mTOR signaling, and provide a rationale for mTOR-targeted therapies, including topical rapamycin, in the treatment of fibrofolliculomas.<\/jats:p>","DOI":"10.1097\/dad.0000000000003336","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T07:00:12Z","timestamp":1782457212000},"page":"617-621","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dermal Interstitial Glycogenosis and Stromal Senescence-Associated Marker Expression in Fibrofolliculomas: Implications for Pathogenesis and mTOR-Targeted Therapy"],"prefix":"10.1097","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4003-7193","authenticated-orcid":false,"given":"Rosalynn M.","family":"Nazarian","sequence":"first","affiliation":[{"name":"Department of Dermatology, Boston University School of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Miyagi","sequence":"additional","affiliation":[{"name":"Molecular Pathology & Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Nakatani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Yokosuka Kyosai Hospital, Yokosuka, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"R2-20260722","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/s41431-024-01671-2","article-title":"ERN GENTURIS clinical practice guidelines for the diagnosis, surveillance and management of people with Birt-Hogg-Dub\u00e9 syndrome","volume":"32","author":"Geilswijk","year":"2024","journal-title":"Eur J Hum Genet."},{"key":"R3-20260722","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/PAS.0b013e3182475240","article-title":"Pulmonary cysts of Birt-Hogg-Dub\u00e9 syndrome: a clinicopathologic and immunohistochemical study of 9 families","volume":"36","author":"Furuya","year":"2012","journal-title":"Am J Surg Pathol."},{"key":"R4-20260722","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/pin.13383","article-title":"Pulmonary interstitial glycogenosis in Birt-Hogg-Dub\u00e9 syndrome-associated lung cysts: a new insight into the pathogenesis?","volume":"73","author":"Kawachi","year":"2023","journal-title":"Pathol Int."},{"issue":"5","key":"R5-20260722","doi-asserted-by":"crossref","DOI":"10.1111\/pin.70127","article-title":"Pulmonary interstitial glycogenosis as a developmental marker of BHD-associated lung cysts: diagnostic and pathogenetic implications","volume":"76","author":"Nemoto","year":"2026","journal-title":"Pathol Int"},{"key":"R6-20260722","doi-asserted-by":"crossref","first-page":"e194300","DOI":"10.1172\/JCI194300","article-title":"Hyperactivation of mTORC1 signaling mediates folliculin deficiency-induced pulmonary cyst formation in Birt-Hogg-Dub\u00e9 syndrome","volume":"136","author":"Cao","year":"2026","journal-title":"J Clin Invest."},{"key":"R7-20260722","doi-asserted-by":"crossref","first-page":"e1800033","DOI":"10.1002\/bies.201800033","article-title":"Glycogen at the crossroad of stress resistance, energy maintenance, and pathophysiology of aging","volume":"40","author":"Gusarov","year":"2018","journal-title":"Bioessays"},{"key":"R8-20260722","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1474-9726.2008.00436.x","article-title":"Enhanced glycogenesis is involved in cellular senescence via GSK3\/GS modulation","volume":"7","author":"Seo","year":"2008","journal-title":"Aging Cell"},{"key":"R9-20260722","doi-asserted-by":"crossref","first-page":"00776-2024","DOI":"10.1183\/23120541.00776-2024","article-title":"Placental transmogrification of the lung in AKT1-related Proteus syndrome","volume":"11","author":"Nakajima","year":"2025","journal-title":"ERJ Open Res."},{"key":"R10-20260722","doi-asserted-by":"crossref","first-page":"e232226","DOI":"10.1136\/bcr-2019-232226","article-title":"Breast cancer in a patient with Birt-Hogg-Dub\u00e9 syndrome (BHDS) with dramatic response to neoadjuvant chemotherapy","volume":"13","author":"Yadala","year":"2020","journal-title":"BMJ Case Rep."},{"key":"R11-20260722","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1600-0560.2009.01198.x","article-title":"Fibrofolliculoma\/trichodiscoma and fibrous papule (perifollicular fibroma\/angiofibroma): a revaluation of the histopathological and immunohistochemical features","volume":"36","author":"Misago","year":"2009","journal-title":"J Cutan Pathol."},{"key":"R12-20260722","doi-asserted-by":"crossref","first-page":"957616","DOI":"10.3389\/fendo.2022.957616","article-title":"Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH","volume":"13","author":"Bonnet","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"R13-20260722","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/cancers15071927","article-title":"Senescent stromal cells in the tumor microenvironment: victims or accomplices?","volume":"15","author":"Ye","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R14-20260722","doi-asserted-by":"crossref","first-page":"1297637","DOI":"10.3389\/fphys.2023.1297637","article-title":"The role of cellular senescence in skin aging and age-related skin pathologies","volume":"14","author":"Chin","year":"2023","journal-title":"Front Physiol."},{"key":"R15-20260722","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/s41586-023-06172-8","article-title":"Signalling by senescent melanocytes hyperactivates hair growth","volume":"618","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"R16-20260722","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/cup.13411","article-title":"Differential expression of phospho-S6 in hair follicle tumors: evidence of mammalian target of rapamycin pathway activation","volume":"46","author":"Sardi\u00f1a","year":"2019","journal-title":"J Cutan Pathol."},{"key":"R17-20260722","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/DSS.0000000000004671","article-title":"Cutaneous fibrofolliculomas and trichodiscomas in Birt-Hogg-Dub\u00e9 syndrome: a review of therapeutic surgical strategies","volume":"51","author":"Fostier","year":"2025","journal-title":"Dermatol Surg."},{"key":"R18-20260722","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1097\/DSS.0000000000001778","article-title":"Laser-assisted delivery of topical rapamycin: mTOR inhibition for Birt-Hogg-Dube syndrome","volume":"45","author":"Kim","year":"2019","journal-title":"Dermatol Surg."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:34:06Z","timestamp":1787747646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":17,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003336","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]}}}